These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 8780417

  • 1. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D.
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [Abstract] [Full Text] [Related]

  • 2. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV.
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 4. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
    Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A.
    Am J Psychiatry; 2001 Feb; 158(2):282-8. PubMed ID: 11156812
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.
    Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K.
    Arch Gen Psychiatry; 1995 Jun; 52(6):434-43. PubMed ID: 7771913
    [Abstract] [Full Text] [Related]

  • 6. A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response.
    Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S.
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):199-204. PubMed ID: 8428872
    [Abstract] [Full Text] [Related]

  • 7. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
    Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S.
    Biol Psychiatry; 2005 Mar 01; 57(5):456-63. PubMed ID: 15737659
    [Abstract] [Full Text] [Related]

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 01; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 9. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.
    Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A.
    J Clin Psychopharmacol; 1999 Jun 01; 19(3):257-64. PubMed ID: 10350032
    [Abstract] [Full Text] [Related]

  • 10. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.
    Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV.
    Am J Psychiatry; 1995 Nov 01; 152(11):1652-8. PubMed ID: 7485630
    [Abstract] [Full Text] [Related]

  • 11. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
    Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF.
    Am J Psychiatry; 2001 Jul 01; 158(7):1067-74. PubMed ID: 11431228
    [Abstract] [Full Text] [Related]

  • 12. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE, Kowatch RA, Carmody T, Rush AJ.
    Am J Psychiatry; 2005 Jan 01; 162(1):58-64. PubMed ID: 15625202
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV, Glatt SJ.
    J Clin Psychiatry; 2010 Jun 01; 71(6):754-63. PubMed ID: 20051220
    [Abstract] [Full Text] [Related]

  • 14. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.
    J Child Adolesc Psychopharmacol; 2011 Apr 01; 21(2):97-110. PubMed ID: 21488751
    [Abstract] [Full Text] [Related]

  • 15. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
    Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA, Modafinil ADHD Study Group.
    J Clin Psychiatry; 2006 May 01; 67(5):727-35. PubMed ID: 16841622
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec 01; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

  • 17. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
    Wilens TE, Bukstein O, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha S.
    J Am Acad Child Adolesc Psychiatry; 2012 Jan 01; 51(1):74-85.e2. PubMed ID: 22176941
    [Abstract] [Full Text] [Related]

  • 18. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, Faraone SV.
    J Clin Psychiatry; 2013 Mar 01; 74(3):e197-204. PubMed ID: 23561240
    [Abstract] [Full Text] [Related]

  • 19. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB.
    Pediatrics; 1995 Jan 01; 95(1):74-81. PubMed ID: 7770313
    [Abstract] [Full Text] [Related]

  • 20. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov 01; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.